Chronic Kidney Disease, Cardiovascular Risk, and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction
- 14 December 2004
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 110 (24), 3667-3673
- https://doi.org/10.1161/01.cir.0000149806.01354.bf
Abstract
Background— Persons with end-stage renal disease and those with lesser degrees of chronic kidney disease (CKD) have an increased risk of death after myocardial infarction (MI) that is not fully exp...This publication has 18 references indexed in Scilit:
- National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and StratificationAnnals of Internal Medicine, 2003
- Acute Myocardial Infarction and Renal Dysfunction: A High-Risk CombinationAnnals of Internal Medicine, 2002
- Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly PatientsAnnals of Internal Medicine, 2002
- Cardiovascular disease risk status in elderly persons with renal insufficiencyKidney International, 2002
- The prognostic importance of creatinine clearance after acute myocardial infarctionEuropean Heart Journal, 2002
- Leptin and renal diseaseAmerican Journal of Kidney Diseases, 2002
- Determinants of mortality after myocardial infarction in patients with advanced renal dysfunctionAmerican Journal of Kidney Diseases, 2001
- Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized TrialAnnals of Internal Medicine, 2001
- The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunctionJournal of the American College of Cardiology, 2000
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionThe New England Journal of Medicine, 1992